Browse > Article
http://dx.doi.org/10.15204/jkobgy.2019.32.4.055

A Review on Korean Traditional Medicine Research against Human Papillomavirus Infection and Cervical Dysplasia - Focused on Randomized Controlled Trial of Human Papillomavirus Infection and Cervical Dysplasia -  

Chung, Jae-Ryung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Jin-Moo (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Jang, Jun-Bock (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Chang-Hoon (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.32, no.4, 2019 , pp. 55-66 More about this Journal
Abstract
Objectives: This review is to figure out evidence that suggests the effectiveness of Korean Medicine treatments against Human Papilloma virus (HPV) infection and Cervical Dysplasia. Methods: Studies on HPV infection and cervical dysplasia were searched through 5 databases: Oriental Medicine Advanced Searching Integrated System (OASIS), Korean Studies Information Service System (KISS), the Journal of Korean Obstetrics & Gynecology, China Academic Journal (CAJ), Pubmed. After that, the articles were extracted with reference point of Korean Traditional Medicine. Results: 21 studies were included lastly according to selection criteria. In 21 studies, HPV turning - negative rate of Korean Medicine treatment group was higher than the control treatment group. Conclusions: 21 studies indicates that Korean Medicine treatment is effective in HPV infection and Cervical Dysplasia.
Keywords
Korean Traditional Medicine; Human Papilloma Virus (HPV) Infection; Cervical Dysplasia; Cervical Intraepithelial Neoplasia;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 World Health Organization, Department of Immunization, Vaccines and Biologicals. Human papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Geneva:WHO 2007.
2 The society of Korean obstetrics and gynecology. Korean obstetrics and Gynecology. Vol. 2. Seoul:Euisungdang. 2012:337-8.
3 De Villiers EM, et al. Classification of papillomaviruses. Virology. 2004;324(1):17-27.   DOI
4 Koshiol J. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol. 2008;168(2):123-37.   DOI
5 Park CS, Jung HS, Sohn YJ. Clinical Study on 3 Cases of Cervical Dysplasia. The Journal of Obstetrics and Gynecology. 2008;21(4):237-46.
6 Ramchandani SM et al. Predicting persistent/recurrent disease in the cervix after excisional biopsy. Medscape General Medicine. 2007;9(2):24.
7 Dou BF, et al. Analysis on effect of Modified Simiao Decoction in treatment of cervical HPV infection. Liaoning J Trad Chin Med. 2013;40(6):1141-2.
8 Liu M. Observation on Clinical Effects of Modified Simiao decoction as adjunctive therapy in treating cervical HPV infection. Western J of Trad Chin Med. 2019;32(01):98-101.
9 He JM, et al. Influence of Yiqi Huashi Jiedu Decoction on TCM symptom score and HPV turn rate of cervicitis with HPV infection. Chin Arch Trad Chin Med. 2015;33(10):2390-2.
10 Xia N. The clinical observation of modified Er Miao granules in the treatment of HR-HPV persistent infection combined with CIN 1 and it's effect on local T lymphocyte subsets of the cervix. Nanjing Univ. of Chin Med. 2018.
11 Mai LX, et al. Effect of treatment by Chinese herbs for subclinical papillomavirus infection (SPI) and change of T cell subpopulation. Liaoning J Trad Chin Med. 2016;43(4):750-2.
12 Bian ML, et al. The efficacy of baofukang suppository for treatment of cervicitis combined with persistant HPV infection. Chin J Pract Gynecol Obstet. 2010;8(26):383-5.
13 Shen JJ, et al. The clinical observation for Baofukang and interferon in promoting the regression of low-grade cervical intraepithelial neoplasia. Chin J Clin Obstet Gynecol. 2013;14(5):509-12.
14 Wang YH, et al. Clinical study on treatment of cervical HPV infection by Radix Sophorae Flavescentis ointment. Med J Natl Defending Forces Southwest China. 2013;23(2):189-91.
15 Zhang Y, et al. Treatment of female patients with vaginal and cervical HPV infection. Chin J Infect Chemother. 2007;7(4):293-4.   DOI
16 Zhang MY. Clinical study on the interventive effect of realgar on the clearance of HPV and CIN. J Clin Exp Med. 2012;18(11):580-1.
17 Ma XL, et al. Clinical study of Zibai gel on treatment of cervical high-risk human papillomavirus infection. Chin J Inform TCM. 2012;19(6):9-12.
18 Xiao J, Wu J, Yu B. Therapeutic Efficacy of Youdujing Preparation in Treating Cervical High-risk Human Papilloma Virus Infection Patients. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012;32(9):1212-5.
19 Xu YX, et al. Study of Therapeutic Efficacy of Er huang Powder on CIN with HPV Infection. J of Liaoning Chin Med. 2013;40(9):1826-7.
20 Chi Y, et al. Ezhuyou-N-CWS carrier suppository for antagonizing HPV infection and preventing cervical cancer. J Beijing Univ Trad Chin Med. 2009;32(6):419-21.   DOI
21 Wang Y, et al. Clinical study of CO2 laser combined with Baofukang suppository in the treatment of vaginal intraepithelial neoplasia with high risk HPV infection. Oncol Prog. 2016;14(5):441-8.
22 Li MX, et al. Effects of treatment efficacy and immune function of recombinant human interferon ${\alpha}$-2b with Baofukang vaginal for patients combined with human papilomavirus infection. Chin J Nosocomiol. 2016;14(26):3296-8.
23 Fu C, et al. Clinical Observation on Microwave Therapy Associated with Baofukang suppository in Treating CIN 1 and HPV infection. Anti Iumor Pharmacy. 2012;5(2):145-7.
24 Yu J, et al. Clinical study on the treatment of high risk HPV infection. Chin J Nosocomiol. 2016;26(13):3069-71.
25 Xu JQ, et al. Clinical observation of Baofukang combined with interferon in the treatment of cervical erosion complicated with HPV infection. Chin Arch Trad Chin Med. 2014;8(32):2028-30.
26 Tang QJ, et al. Clinical study of cervical HPV infection treated by Jiawei Jianpi Decoction combined with XinFuNing. Shanghai J Trad Chin Med. 2016;50(4):55-7.
27 Xu X, et al. Combined use of Xunxi No. 1 and radiotherapy have clinical benefits in stage Ia-IIb cervical cancer patients with high-risk human papilloma virus infection. Minerva Biotecnol. 2014;26(4):309-13.
28 Dunne EF, et al. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis. 2006;194(8):1044-57.   DOI
29 Stanley M. Immune response to human papillomavirus. Vaccine. 2006;24(Suppl 1):S16-22.   DOI
30 Kyrgiou M, et al. Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neolplasia: systemic review and meta-analysis. BMJ. 2014;349:6192-208.   DOI
31 The society of obstetrics and gynecology. Gynecology. Vol. 5. Seoul:Korea medical publishing company. 2015:373-406.
32 Santesso N, et al. Systematic reviews and meta- analysis of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. International Journal of Gynecology and Obstetrics. 2015;132(3):266-71.   DOI